Amgen's heart drug reduces cardiovascular disease risk factor in phase 2 trial

Amgen's heart drug reduces cardiovascular disease risk factor in phase 2 trial aarmstrong Wed, 06/01/2022 - 11:02... Read more

Bron:

FierceBiotech